Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 8/2020

15.05.2020 | Review

Antiemetic Prophylaxis and Anesthetic Approaches to Reduce Postoperative Nausea and Vomiting in Bariatric Surgery Patients: a Systematic Review

verfasst von: Zaina Naeem, Ingrid L. Chen, Aurora D. Pryor, Salvatore Docimo, Tong J. Gan, Konstantinos Spaniolas

Erschienen in: Obesity Surgery | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

While guidelines exist for the management of postoperative nausea and vomiting (PONV) in the general surgical setting, there are no established guidelines for the prevention or treatment of PONV in bariatric patients, in whom PONV contributes significantly to perioperative morbidity and hospital resource utilization. This systematic review found that the multimodal pharmacological approach to PONV prevention recommended in current guidelines for high-risk surgical patients is appropriate for the bariatric subset. This includes multi-agent antiemetic prophylaxis with dexamethasone and one or more agents from other classes, and opioid-free total intravenous anesthesia, though the advantages of the latter need further evaluation. There remains a need for a standardized validated instrument to assess PONV in the bariatric setting.
Literatur
1.
Mendes MN, Monteiro RS, Martins FANC. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties. A comparative study among three methods. Rev Bras Anestesiol. 2009;59(5):570–6.PubMed
2.
Fathy M, Abdel-Razik MA, Elshobaky A, et al. Impact of pyloric injection of magnesium sulfate-lidocaine mixture on postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a randomized-controlled trial. Obes Surg. 2019;29(5):1614–23.PubMedCrossRef
3.
Celio A, Bayouth L, Burruss MB, et al. Prospective assessment of postoperative nausea early after bariatric surgery. Obes Surg. 2019;29(3):858–61.PubMedCrossRef
4.
Markic J, Ridge AL. Promethazine in the treatment of postoperative nausea and vomiting: a systematic review. Signa Vitae. 2011;6(2):9–16.CrossRef
5.
Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693–700.PubMedCrossRef
6.
Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.PubMedCrossRef
7.
Sinha AC, Singh PM, Williams NW, et al. Aprepitant’s prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2013;24(2):225–31.CrossRef
8.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef
9.
Groene P, Eisenlohr J, Zeuzem C, et al. Postoperative nausea and vomiting in bariatric surgery in comparison to non-bariatric gastric surgery. Wideochir Inne Tech Maloinwazyjne. 2019;14(1):90–5.PubMed
10.
Moussa AA, Oregan PJ. Prevention of postoperative nausea and vomiting in patients undergoing laparosopic bariatric surgery: granisetron alone vs granisetron combined with dexamethasone/droperidol. MEJ Anesth. 2007;19(2):357–68.
11.
Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg. 2013;23(9):1389–96.PubMedCrossRef
12.
Didehvar S, Viola-Blitz JD, Haile M, et al. A randomized, double blind study to evaluate the efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of post-operative nausea and vomiting in subjects undergoing bariatric surgeries with high emetogenic risk. The Open Anesthesiology Journal. 2013;7:30–6.CrossRef
13.
Bataille A, Letourneulx JF, Charmeau A, et al. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: a randomised double-blind placebo-controlled study. Eur J Anaesthesiol. 2016;33(12):898–905.PubMedCrossRef
14.
Halliday TA, Sundqvist J, Hultin M, et al. Post-operative nausea and vomiting in bariatric surgery patients: an observational study. Acta Anaesthesiol Scand. 2017;61(5):471–9.PubMedCrossRef
15.
Therneau IW, Martin EE, Sprung J, et al. The role of aprepitant in prevention of postoperative nausea and vomiting after bariatric surgery. Obes Surg. 2017;28(1):37–43.CrossRef
16.
Zhao LP, Zou LJ, He JH. Postoperative vomiting/nausea in Chinese patients undergoing bariatric surgery. Trop J Pharm Res. 2019;18(10):2211–7.CrossRef
17.
Suh S, Helm M, Kindel TL, Goldblatt MI, Gould JC, Higgins RM. The impact of nausea on post-operative outcomes in bariatric surgery patients. Surg Endosc. 2019.
18.
Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906–11.PubMedCrossRef
19.
Nordin L, Nordlund A, Lindqvist A, et al. Corticosteroids or not for postoperative nausea: a double-blinded randomized study. J Gastrointest Surg. 2016;20(8):1517–22.PubMedCrossRef
20.
Boogaerts JG, Vanacker E, Seidel L, et al. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand. 2000;44:470–4.PubMedCrossRef
21.
Aftab H, Fagerland MW, Gondal G, et al. Pain and nausea after bariatric surgery with total intravenous anesthesia versus desflurane anesthesia: a double blind, randomized, controlled trial. Surg Obes Relat Dis. 2019;15(9):1505–12.PubMedCrossRef
22.
Bamgbade OA, Oluwole O, Khaw RR. Perioperative antiemetic therapy for fast-track laparoscopic bariatric surgery. Obes Surg. 2018;28(5):1296–301.PubMedCrossRef
23.
Ziemann-Gimmel P, Hensel P, Koppman J, et al. Multimodal analgesia reduces narcotic requirements and antiemetic rescue medication in laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2013;9(6):975–80.PubMedCrossRef
24.
Myles PS, Wengritzky R. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Br J Anaesth. 2012;108(3):423–9.PubMedCrossRef
25.
Talebpour M, Ghiasnejad Omrani N, Imani F, et al. Comparison effect of promethazine/dexamethasone and metoclopramide /dexamethasone on postoperative nausea and vomiting after laparascopic gastric placation: a randomized clinical trial. Anesth Pain Med. 2017;7(4):e57810.PubMedPubMedCentralCrossRef
26.
Lindley CM, Hirsch JD, O'Neill CV, et al. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res. 1992;1(5):331–40.PubMedCrossRef
27.
Alimian M, Abedian AE, Entezari S, et al. Comparison of the effect of intraoperative 1 mg/kg/h and 2 mg/kg/h IV lidocaine infusion on postoperative pain and nausea-vomiting in laparoscopic gastric bypass surgery. Journal of Pharmaceutical Research International. 2019:1–9.
28.
Schuster R, Alami RS, Curet MJ, et al. Intra-operative fluid volume influences postoperative nausea and vomiting after laparoscopic gastric bypass surgery. Obes Surg. 2006;16:848–51.PubMedCrossRef
29.
Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92:958–67.PubMedCrossRef
30.
Kim EJ, Ko JS, Kim CS, et al. Combination of antiemetics for the prevention of postoperative nausea and vomiting in high-risk patients. J Korean Med Sci. 2007;22:878–82.PubMedPubMedCentralCrossRef
31.
Delgado DA, Lambert BS, Boutris N, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088.PubMedPubMedCentral
32.
Rhodes VA, McDaniel RW. The index of nausea, vomiting, and retching: a new format of the index of nausea and vomiting. Oncol Nurs Forum. 1999;26(5):889–94.PubMed
33.
Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms. Surg Endosc. 2015;29(1):41–7.PubMedCrossRef
34.
Hauser JM, Azzam JS, Kasi A. Antiemetic Medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Updated 2019 Nov 25].
35.
Pierre S, Whelan R. Nausea and vomiting after surgery. Continuing Education in Anaesthesia Critical Care & Pain. 2013;13(1):28–32.CrossRef
36.
Bergese SD, Antor MA, Uribe AA, et al. Triple therapy with scopolamine, ondansetron, and dexamethasone for prevention of postoperative nausea and vomiting in moderate to high-risk patients undergoing craniotomy under general anesthesia: a pilot study. Front Med (Lausanne). 2015;2:40.
37.
Chatterjee S, Rudra A, Sengupta S. Current concepts in the management of postoperative nausea and vomiting. Anesthesiol Res Pract. 2011;2011:748031.PubMedPubMedCentral
38.
Antor MA, Uribe AA, Erminy-Falcon N, et al. The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting. Front Pharmacol. 2014;5
39.
Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742–53.PubMedCrossRef
40.
Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol. 2005;19(3):485–500.PubMedCrossRef
41.
Junger A, Hartmann B Fau-Benson M, Benson M Fau-Schindler E, et al. The use of an anesthesia information management system for prediction of antiemetic rescue treatment at the postanesthesia care unit. (0003-2999 (Print)).
42.
White PF, O'Hara JF, Roberson CR, et al. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg. 2008;107(2):452–8.PubMedCrossRef
43.
Alimian M, Imani F, Faiz SH, et al. Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesth Pain Med. 2012;2(1):12–6.PubMedPubMedCentralCrossRef
44.
Wojcikiewicz TG, Jeans J, Karmali A, et al. The use of high-dose intrathecal diamorphine in laparoscopic bariatric surgery: a single-centre retrospective cohort study. Br J Pain. 2019;13(2):106–11.PubMedCrossRef
45.
Symons JL, Kemmeter PR, Davis AT, et al. A double-blinded, prospective randomized controlled trial of intraperitoneal bupivacaine in laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2007;204(3):392–8.PubMedCrossRef
46.
Ruiz-Tovar J, Garcia A, Ferrigni C, et al. Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial. Surg Obes Relat Dis. 2019;15(2):228–35.PubMedCrossRef
47.
Major P, Stefura TA, Malczak P, et al. Postoperative care and functional recovery after laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass among patients under ERAS protocol. Obes Surg. 2018;28(4):1031–9.PubMedCrossRef
48.
King AB, Spann MD, Jablonski P, et al. An enhanced recovery program for bariatric surgical patients significantly reduces perioperative opioid consumption and postoperative nausea. Surg Obes Relat Dis. 2018;14(6):849–56.PubMedCrossRef
Metadaten
Titel
Antiemetic Prophylaxis and Anesthetic Approaches to Reduce Postoperative Nausea and Vomiting in Bariatric Surgery Patients: a Systematic Review
verfasst von
Zaina Naeem
Ingrid L. Chen
Aurora D. Pryor
Salvatore Docimo
Tong J. Gan
Konstantinos Spaniolas
Publikationsdatum
15.05.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 8/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04683-1

Weitere Artikel der Ausgabe 8/2020

Obesity Surgery 8/2020 Zur Ausgabe

Brief Communication

An Effective Way to Treat Hyperammonemic Encephalopathy Complicated Post-Distal Roux-en-Y Gastric Bypass Surgery

Biography

Biography: Sylvia Weiner, MD, PhD

Original Contributions

A Qualitative Exploration of Patients’ Experiences with Lifestyle Changes After Sleeve Gastrectomy in China

Brief Communication

Spontaneous Splenic Rupture Two Weeks After Sleeve Gastrectomy

Review

Missing Something? Comparisons of Effectiveness and Outcomes of Bariatric Surgery Procedures and Their Preferred Reporting: Refining the Evidence Base

Review

IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.